Sign up
Log in
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Firefly Neuroscience (NASDAQ:AIFF) stock rose 19.6% to $3.59 during Friday's pre-market session. The company's market cap stands at $38.5 million.
  • Quantum BioPharma (NASDAQ:QNTM) stock moved upwards by 18.45% to $35.75. The market value of their outstanding shares is at $87.7 million.
  • Processa Pharmaceuticals (NASDAQ:PCSA) shares moved upwards by 17.97% to $0.29. The market value of their outstanding shares is at $2.8 million.
  • Vivos Therapeutics (NASDAQ:VVOS) stock moved upwards by 12.09% to $2.78. The market value of their outstanding shares is at $14.6 million.
  • Semler Scientific (NASDAQ:SMLR) shares moved upwards by 11.87% to $35.73. The company's market cap stands at $419.7 million.
  • Galmed Pharmaceuticals (NASDAQ:GLMD) shares increased by 11.79% to $1.99. The market value of their outstanding shares is at $4.0 million.

Losers

  • Regencell Bioscience (NASDAQ:RGC) shares declined by 18.4% to $51.7 during Friday's pre-market session. The market value of their outstanding shares is at $824.3 million.
  • Terns Pharma (NASDAQ:TERN) shares decreased by 16.75% to $3.33. The market value of their outstanding shares is at $349.3 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares declined by 14.24% to $4.4. The company's market cap stands at $3.4 million.
  • Co-Diagnostics (NASDAQ:CODX) stock declined by 11.66% to $0.25. The market value of their outstanding shares is at $9.4 million.
  • Insight Molecular (NASDAQ:IMDX) shares decreased by 11.4% to $2.8. The company's market cap stands at $90.3 million.
  • Opus Genetics (NASDAQ:IRD) shares fell 10.75% to $0.83. The market value of their outstanding shares is at $55.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.